The importance of monitoring sST2 levels during HF hospitalization was underscored in a study involving 150 acute HF patients, where the percentage change in sST2 predicted 3-month mortality, irrespective of BNP or NT-proBNP levels [60]. This evidence concerns the gene NPPB and hydrops fetalis.